News
In this GEN webinar, Dave Lahr, PhD, Senior Director of Bioinformatics at Foghorn Therapeutics, discusses chromatin regulation and epigenetic mechanisms that shape transcriptional responses to ...
Newfound mechanism rewires cellular energy processing for drastic weight loss Date: May 22, 2025 Source: NYU Langone Health / NYU Grossman School of Medicine Summary: Mice genetically engineered ...
(RTTNews) - CytoDyn Inc. (CYDY.OB), a biotechnology company, Tuesday announced new data suggesting a novel mechanism of action of leronlimab for the treatment of solid tumors.
Theralase(R) Has Discovered a New Mechanism of Action in Its War on Cancer; Specifically, Ruvidar’s(TM) Ability to Inhibit DeUbiquitinating Enzymes, an Important Class of Enzymes Which Have Been ...
Circle Pharma, a clinical-stage biopharmaceutical company focused on developing cell-permeable macrocycle therapeutics, today announced a late-breaking poste ...
How Well Did the Mysterious Antikythera Mechanism Actually Work? Historians think the 2,000-year-old device was used to predict the positions of celestial bodies. A new digital simulation suggests ...
“This elucidation of MIPLYFFA’s ® highly differentiated mechanism of action marks a critical step in understanding its interactions with Niemann-Pick disease type C (NPC) at a cellular level ...
Within the past decade, much attention has been drawn to antimicrobial textiles due to their vast potential for reducing the spread of infectious diseases and improving hygiene standards in various ...
This finding is consistent with 8-azaguanine’s known mechanism of action as an antimetabolite that resembles the purine base guanine (42) and reportedly the polyploid-specific disruptor of ...
With this approval, we'll have a unique mechanism of action. We'll have another treatment option [with] reduced resistance due to its mechanism of action, and I think that's really going to drive ...
Amphista Therapeutics to present novel mechanism of action for the degradation of BRD9 using its proprietary Targeted Glue® technology at two key upcoming scientific conferences Oral presentations ...
Previously known as JNJ-2113, icotrokinra (Protagonist Therapeutics, Johnson & Johnson) has a very specific mechanism of action for the treatment of moderate to severe plaque psoriasis, according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results